Chevy Chase Trust’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
CDH
BW
Chevy Chase Trust's NWBO Position: Q4 2016 in Review
Chevy Chase Trust sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 37,854 shares — an estimated $21K sold.
Chevy Chase Trust first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $366K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.
- Chevy Chase Trust reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
- Chevy Chase Trust sold 37,854 Northwest Biotherapeutics shares in Q4 2016, an estimated $21K.
- Chevy Chase Trust first reported a position in Northwest Biotherapeutics in Q4 2013 and held it in 12 quarters.
- Chevy Chase Trust's Northwest Biotherapeutics position peaked at $366K in Q2 2015.
- 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.
Based on Chevy Chase Trust's 13F filing for Q4 2016, filed 9 Jan 2017.